Strategies to prevent and treat preeclampsia: Evidence from randomized controlled trials

Seminars in Nephrology

Volumn 24, Issue 6 SPEC.ISS., 2004, Pages 607-615

  Villar, José ^a   Abalos, Edgardo ^b   Nardin, Juan M ^b   Merialdi, Mario ^a   Carroli, Guillermo ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Centro Rosarino de Estudios Perinatales   (Argentina)

Author keywords

antihypertensives; magnesium sulfate; preeclampsia prevention; randomized trials

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM ANTAGONIST; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; CLONIDINE; DIAZEPAM; DIAZOXIDE; FISH OIL; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NIMODIPINE; PHENYTOIN; PRAZOSIN; PROSTACYCLIN; SODIUM CHLORIDE; URAPIDIL;

ALCOHOL CONSUMPTION; CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; ENERGY; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MATERNAL HYPERTENSION; MORBIDITY; MORTALITY; NUTRITION; OBESITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEINURIA; SCREENING; SMALL FOR DATE INFANT; SODIUM RESTRICTION; SOLUTIO PLACENTAE; WORLD HEALTH ORGANIZATION;

EID: 8644281332     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.07.009     Document Type: Conference Paper

References (53)

1. J. Villar, L. Say, M. Gülmezoglu H. Critchley A. Maclean L. Poston Eclampsia and pre-eclampsia A worldwide health problem for 2000 years 2003 RCOG Press Pre-eclampsia London 189 207
2. L. Vatten, R. Skjoerven Is pre-eclampsia more than one disease? Br J Obstet Gynaecol 111 2004 298 302
3. J. Villar, G. Carroli Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions Prev Med 25 1996 365 375
4. J. Villar, M.E. Mackey, G. Carroli Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine Comparison of fixed and random effect model Stat Med 20 2001 3635 3647
5. J. Villar, G. Piaggio, G. Carroli Factors affecting the comparability of meta-analyses and largest trials' results in perinatology J Clin Epidemiol 50 1997 997 1002
6. J. Villar, M. Merialdi, M. Gülmezoglu Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery An overview of randomized controlled trials J Nutr 133 2003 1606S 1625S
7. M. Merialdi, G. Carroli, J. Villar Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth An overview of randomized controlled trials J Nutr 133 2003 1626S 1631S
8. J. Villar, M. Merialdi, M. Gülmezoglu Characteristics of randomized controlled trials included in systematic reviews of nutritional interventions reporting maternal morbidity, mortality, preterm delivery, intrauterine growth restriction and small for gestational age and birth weight outcomes J Nutr 133 2003 1632S 1639S
9. M.S. Kramer Nutritional advice in pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
10. M.S. Kramer Balanced protein/energy supplementation in pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
11. M.S. Kramer Isocaloric balanced protein supplementation in pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
12. M.S. Kramer Energy/protein restriction for high weight-for-height or weight gain during pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
13. J.M. Moutquin, P.R. Garner, R.F. Burrows Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy CMAJ 157 1997 907 919
14. L. Duley, D. Henderson-Smart Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
15. A.N. Atallah, G.J. Hofmeyr, L. Duley Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
16. M. Makrides, C.A. Crowther Magnesium supplementation in pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
17. L. Duley Prophylactic fish oil in pregnancy M.W. Enkin M.J. Keirse M.J. Renfrew Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews 1995 British Medical Journal Publishing Group London
18. L. Chappell, P. Seed, A. Briley Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk A randomized trial Lancet 354 1999 810 816
19. R.L. Ferrer, B.M. Sibai, C.D. Mulrow Management of mild chronic hypertension during pregnancy A review Obstet Gynecol 96 2000 849 860
20. M.D. Lindheimer, E. Abalos Management of high blood pressure in pregnancy M. Epstein Calcium Antagonists in Clinical Medicine 3rd ed 2002 Hanley and Belfus Philadelphia 507 534
21. B. Eskenazi, L. Fenster, S. Sidney A multivariate analysis of risk factors for pre-eclampsia JAMA 266 1991 237 242
22. Royal College of Obstetricians and Gynaecologists Alcohol consumption in pregnancy Guidelines Report 9 1996 Royal College of Obstetricians and Gynaecologists London
23. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy Am J Obstet Gynecol 183 2000 S1 S22
24. A.J. Ingenito, J.P. Barrett, L. Procita A centrally mediated peripheral hypotensive effect of methyldopa J Pharmacol Exp Ther 175 1970 593 599
25. L. Isaac Clonidine in the central nervous system Site of mechanism of hypotensive action J Cardiovasc Pharmacol 2 1980 S5 S19
26. W. Prishman Clinical pharmacology of the new beta-adrenergic drugs. Part. 1. Pharmacodynamic and pharmacokinetic properties Am Heart J 97 1979 663 670
27. B.F. Robinson, R.J. Dobbs, C.R. Kelsey Effects of nifedipine on resistance vessels, arteries and veins in man Br J Clin Pharmacol 10 1980 433 438
28. A. Stunkard, L. Wertheimer, W. Redisch Studies on hydralazine; evidences for a peripheral site of action J Clin Invest 33 1954 1047 1054
29. R.L. Ferrer, B.M. Sibai, C.D. Mulrow Management of mild chronic hypertension during pregnancy A review Obstet Gynecol 96 2000 849 860
30. L.A. Magee, M.P. Ornstein, P. von Dadelszen Management of hypertension in pregnancy BMJ 318 1999 1332 1336
31. E. Abalos, L. Duley, D.W. Steyn Antihypertensive drug therapy for mild to moderate hypertension during pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
32. L.A. Magee, L. Duley Oral beta-blockers for mild to moderate hypertension during pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK in The Cochrane Library, Issue 1.
33. P. von Dadelszen, M.P. Ornstein, S.B. Bull Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension A meta-analysis Lancet 355 2000 87 92
34. C.J. Pickles, F. Broughton Pipkin, E.M. Symonds A randomized placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension Br J Obstet Gynaecol 99 1992 964 968
35. L. Butters, S. Kennedy, P.C. Rubin Atenolol in essential hypertension during pregnancy BMJ 301 1990 587 589
36. D.J. Cruickshank, A.A. Robertson, D.M. Campbell Maternal obstetric outcome measures in a randomized controlled study of labetalol in the treatment of hypertension in pregnancy Clin Exp Hypertens B10 1991 333 334
37. M.A. Brown, M.L. Buddle What's in a name? Problems with the classification of hypertension in pregnancy J Hypertens 15 1997 1049 1054
38. C.W.G. Redman, J.M. Roberts Management of pre-eclampsia Lancet 341 1993 1451 1454
39. B.M. Sibai, M.D. Lindheimer, J. Hauth Risk factors for pre-eclampsia, abruption placentae and adverse neonatal outcomes among women with chronic hypertension N Engl J Med 339 1998 667 671
40. Australian Society for the Study of Hypertension in Pregnancy Consensus statement: Management of hypertension in pregnancy: Executive summary Med J Aust 58 1993 700 702
41. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy CMAJ 157 1997 1254 1254
42. G. Carroli, C. Rooney, J. Villar How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence Paediatr Perinat Epidemiol 15 suppl 1 2001 1 15
43. L. Duley, D.J. Henderson-Smart Drugs for rapid treatment of very high blood pressure during pregnancy 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
44. the Nimodipine Study Group. M. Belfort, J. Anthony, G. Saade Interim report of the nimodipine vs. magnesium sulphate for seizure prophylaxis in severe pre-eclampsia study An international, randomized controlled trial Am J Obstet Gynecol 178 1998 S7
45. L. Duley, J. Williams, D.J. Henderson-Smart Plasma volume expansion for treatment of pre-eclampsia 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
46. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet 345 1995 1455 1463
47. L. Duley, D.J. Henderson-Smart Magnesium sulphate versus diazepam for eclampsia 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
48. L. Duley, D.J. Henderson-Smart Magnesium sulphate versus phenytoin for eclampsia 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
49. Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial A randomized placebo-controlled trial Lancet 359 2002 1877 1890
50. Magpie Trial Follow Up Study Collaborative Group The Magpie Trial Follow Up Study Outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia Biomed Central, Pregnancy Childbirth 2004 [ISRCTN86938761]
51. M. Knight, L. Duley, D.J. Henderson-Smart Antiplatelet agents for preventing and treating pre-eclampsia 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
52. L. Duley, D.J. Henderson-Smart, M. Knight Antiplatelet agents for preventing pre-eclampsia and its complications 2004 John Wiley and Sons, Ltd Chichester, UK (Cochrane Review), in The Cochrane Library, Issue 1.
53. J.B. Delee Theories of eclampsia Am J Obstet Gynecol 51 1905 325 330